Pharmaceutical Technology on MSN8d
AstraZeneca to invest $2.5bn in R&D centre in ChinaThe new centre will focus on early-stage research and clinical development, supported by data science and AI labs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback